Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Larimar Therapeutics Inc (NASDAQ: LRMR) closed at $3.55 in the last session, up 0.28% from day before closing price of $3.54. In other words, the price has increased by $0.28 from its previous closing price. On the day, 3.35 million shares were traded. LRMR stock price reached its highest trading level at $3.685 during the session, while it also had its lowest trading level at $3.4.
Ratios:
We take a closer look at LRMR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18. On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26. On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 31 ’25 when Flynn James E bought 9,375,000 shares for $3.20 per share. The transaction valued at 30,000,000 led to the insider holds 9,538,945 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 303845888 and an Enterprise Value of 132757888.
Stock Price History:
The Beta on a monthly basis for LRMR is 1.05, which has changed by -0.41680396 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $6.91, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -11.24%, while the 200-Day Moving Average is calculated to be 11.19%.
Shares Statistics:
According to the various share statistics, LRMR traded on average about 2.60M shares per day over the past 3-months and 1425400 shares per day over the past 10 days. A total of 85.59M shares are outstanding, with a floating share count of 47.71M. Insiders hold about 44.26% of the company’s shares, while institutions hold 57.32% stake in the company. Shares short for LRMR as of 1763078400 were 10075712 with a Short Ratio of 3.88, compared to 1760486400 on 8816753. Therefore, it implies a Short% of Shares Outstanding of 10075712 and a Short% of Float of 17.7.
Earnings Estimates
A detailed examination of Larimar Therapeutics Inc (LRMR) is currently in progress, with 7.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.41 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$1.7 and -$2.18 for the fiscal current year, implying an average EPS of -$1.99. EPS for the following year is -$1.82, with 7.0 analysts recommending between -$1.39 and -$2.54.
